Fabtech Technologies Limited Share Price & Stock Analysis

Fabtech Technologies Limited (NSE: FABTECH, BSE: 544558) is a Mumbai, Maharashtra-based company in the Pharmaceutical Manufacturing Equipment industry. With a market capitalisation of ₹620 Cr, it ranks #1,873 by market cap among the 6,197 Indian listed companies on FinBizNet. At ₹134.90 (as of 19 Nov 2026), the share price is 47.5% below its 52-week high of ₹256.95 and 17.2% above its 52-week low of ₹115.10. The share price is down 42.4% over one year and down 8.3% over three months.

Key Metrics

Current Price₹134.90
Market Cap₹620 Cr
NSE SymbolFABTECH
BSE Code544558
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services
Sub-IndustryLife Sciences Tools and Services > Pharmaceutical Manufacturing Equipment
P/E Ratio14.2
Return on Equity9.14%
Return on Assets3.34%
52-Week Range₹115.10 – ₹256.95
1-Year Price Change-42.4%
3-Month Price Change-8.3%
Beta (1Y)0.34
Dividend Yield0.42%
HeadquartersMumbai, Maharashtra
Websitewww.fabtechnologies.com

Latest Quarterly Results — Q2 FY27

Revenue₹92 Cr
Net Profit₹15 Cr
Net Margin16.3%
EPS (Basic)₹3.38
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Fabtech Technologies Limited Quarterly Revenue and Profit Trend

Fabtech Technologies Limited reported revenue of ₹92 Cr in Q2 FY27, down 24.2% from ₹121 Cr in Q2 FY26 and up 22.8% from ₹75 Cr in Q1 FY27. It posted a net profit of ₹15 Cr for the quarter, against a net profit of ₹28 Cr in Q2 FY26 (down 46.6%). Across the 6 quarters from Q1 FY26 to Q2 FY27, quarterly revenue ranged from ₹63 Cr (Q3 FY26) to ₹159 Cr (Q4 FY26). The company reported a net loss in 2 of these 6 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹92 Cr₹15 Cr16.3%
Q1 FY27₹75 Cr₹4 Cr5.6%
Q4 FY26₹159 Cr₹22 Cr13.9%
Q3 FY26₹63 Cr−₹6 Cr−9.1%
Q2 FY26₹121 Cr₹28 Cr23.1%
Q1 FY26₹68 Cr−₹6 Cr−9.0%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 69.03% of Fabtech Technologies Limited's shares as of Sept 2026, against 68.94% in Oct 2025 (+0.09 percentage points). Delivery averaged 48.5% of traded volume across 18 NSE sessions (26 Oct 2026 – 19 Nov 2026).

About Fabtech Technologies Limited

Fabtech Technologies Limited operates as a biopharma engineering company that provides aseptic manufacturing facilities internationally. The company offers designing, engineering, procurement, installation, and testing of pharmaceutical equipment. It serves pharmaceuticals, biotech, and healthcare companies. The company was founded in 2001 and is based in Mumbai, India.

Products and Services

1. Surgical & Medical Equipment-This segment engages in the provision of turnkey project solutions to pharmaceuticals and allied industries. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Surgical & Medical Equipment-100%

Frequently Asked Questions

What is the current share price of Fabtech Technologies Limited?

Fabtech Technologies Limited is trading at ₹134.90, with a market capitalisation of ₹620 Cr.

Which sector does Fabtech Technologies Limited belong to?

Fabtech Technologies Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services space (Life Sciences Tools and Services > Pharmaceutical Manufacturing Equipment).

What are the key financial ratios of Fabtech Technologies Limited?

Fabtech Technologies Limited has a P/E of 14.2 and a return on equity of 9.14%.

What is the stock symbol of Fabtech Technologies Limited?

Fabtech Technologies Limited is listed on the NSE under the symbol FABTECH and on the BSE under the scrip code 544558.

How has Fabtech Technologies Limited's share price moved over the past year?

Fabtech Technologies Limited's share price is down 42.4% over one year and down 8.3% over three months. Its 52-week range is ₹115.10 to ₹256.95.

What were Fabtech Technologies Limited's latest quarterly results?

In Q2 FY27, Fabtech Technologies Limited reported revenue of ₹92 Cr and net profit of ₹15 Cr, with basic EPS of ₹3.38 (consolidated, parsed from the company's exchange filing).

How have Fabtech Technologies Limited's revenue and profit changed over the past year?

Fabtech Technologies Limited reported revenue of ₹92 Cr in Q2 FY27, down 24.2% from ₹121 Cr in Q2 FY26 and up 22.8% from ₹75 Cr in Q1 FY27.

What is the promoter holding in Fabtech Technologies Limited?

Promoters held 69.03% of Fabtech Technologies Limited's shares as of Sept 2026, against 68.94% in Oct 2025 (+0.09 percentage points).

More on FinBizNet

Data as of 19 Nov 2026. Descriptive market data only — not investment advice.